// App-Quantinova.ai

84 P-3-738 : Prestarium Pharmacogenetic Efficacy in Predicting Diabetic Nephropathy in Children and Adolescents

Researchers

Presenter

  • Gulnara Rakhimova

Principal Investigators

  • Akida Sadikova

Medical Centers

  • Center for the Scientific and Clinical Study of Endocrinology, Tashkent, Uzbekistan

Locations

  • Uzbekistan

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Type 1 diabetes mellitus

  • Diabetic nephropathy

  • Diabetes

  • Renal disease

  • Albuminuria

Biomarkers

  • Creatinine

  • Hemoglobin A1c

Drug/Treatment

  • Fibrinogen (IV)

  • Prestarium

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved